# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Team composed of former FDA officials and key clinical and regulatory opinion leaders to help provide insight in preparation fo...
Lemonaid Health will offer customers more affordable access to branded ED medication STENDRA that may be taken as early as ~15 ...
- SEC Filing